If your estrogen patch is out of stock, you are dealing with a real shortage, and it is happening across the country. Weight Watchers’ article on the shortage, which carries no publication date, says at least two major patch makers are reporting shortages of some popular brands and doses. Your best next step is to call your prescriber, who can move you to another pharmacy, brand, dose or form of estrogen, rather than stretching or skipping your patch on your own.
Why are estrogen patches hard to fill?
Weight Watchers’ article says demand for estrogen patches has grown greater than the supply. Bradley Gynecology, a women’s health clinic, describes the same problem, saying women are having difficulty filling prescriptions “as demand for menopause hormone therapy continues to grow.” The cause, as both describe it, is demand running ahead of the stock on shelves.
Is the estrogen patch shortage still happening?
Yes, for many women. A Bradley Gynecology post dated October 27, 2026 describes women across the country having difficulty filling estrogen patch prescriptions.
The brand list comes from Weight Watchers’ article, which carries no publication date. It says “As of this writing, at least two of the major patch manufacturers are currently reporting shortages,” and names “Sandoz estradiol transdermal patches and several dosages of Dotti and Lyllana transdermal patches made by Amneal” as the hardest to come by. Treat that list as a snapshot from when the article was written. Check your pharmacy or the manufacturer for current status.
The shortage affects some brands and doses, not every patch. Weight Watchers puts it this way: “Not every brand of estrogen patch is in short supply.” If your brand is on that list, ask your prescriber whether a similar patch from another maker could work for you. If it is not, another pharmacy may still have your strength.
How long the shortage will last is not known yet. Ask your pharmacy whether your exact strength is on backorder and when they expect a restock. If you want to know whether a specific brand is still being made, ask your pharmacist or the manufacturer directly.
What are my options if my patch is out of stock?
No single option suits everyone. The right one depends on your symptoms, your health history and your current dose, and your clinician makes that call with you.
| Option | What it is | Who it may suit | Limits |
|---|---|---|---|
| Another pharmacy | Your prescriber sends your existing prescription to a different pharmacy. | Anyone whose usual pharmacy is out of your strength. | Only helps if another pharmacy has your strength in stock. |
| Similar patch from another maker | A patch from a different manufacturer that your prescriber judges could work for you. | People whose brand is on the short list. | Bradley Gynecology says estrogen products “aren’t always interchangeable.” |
| Different patch schedule | A once-weekly patch in place of a twice-weekly one, when clinically suitable. | People whose clinician says the switch fits. | Bradley Gynecology lists this as an option “when appropriate”; your provider decides. |
| Gel, spray, pump or gel packet | Estrogen applied to the arm, thigh or skin once a day instead of a patch. | People whose skin reacts to patches. Weight Watchers notes some patches “fall off too easily” or cause skin irritation. | A different product and routine, so it needs your prescriber’s guidance. |
| Vaginal ring or cream | A flexible ring inserted into the vagina for up to three months, or a vaginal cream. | Women whose main symptoms are vaginal, such as dryness or urinary urgency, per Weight Watchers. | The NIH-hosted review reports that in the Women’s Health Initiative trial, menopausal hormone therapy did not help urinary incontinence and increased its incidence in women who were continent. Ask your clinician whether that finding applies to a vaginal product. |
| Oral estrogen pill | A daily estrogen pill. | Some women, as their clinician judges. | Bradley Gynecology says oral estrogen carries a higher risk of blood clots than transdermal formulations. Weight Watchers says the actual risk is personalized. |
| Non-hormonal medicines | Antidepressants, gabapentin or oxybutynin, according to Cleveland Clinic. The NIH-hosted review also lists venlafaxine, desvenlafaxine, paroxetine (Brisdelle) and others. Weight Watchers quotes Monica Christmas, M.D., calling NK3 receptor antagonists “a highly effective option for managing vasomotor symptoms.” | Women whose clinician suggests a non-hormonal option. | Your clinician will discuss the risks and benefits of each with you. |
| Lifestyle changes and over-the-counter moisturizers | Cleveland Clinic says many people find that lifestyle changes alone make a big difference. Over-the-counter lubricants and moisturizers may help milder vaginal symptoms, according to the NIH-hosted review. | People with milder symptoms. | The NIH-hosted review says that for severe symptoms, hormonal treatment is the mainstay. |
Your prescriber might also send your prescription to another pharmacy first. Weight Watchers’ article puts it simply: “what’s on backorder at one place may still be on the shelves at another.”
What does the research show about estrogen patches?
The estrogen patch has been studied for years, and most of the studies below look at hot flashes or at the patch’s effect on cholesterol and heart outcomes. An NIH-hosted menopause symptoms review says hot flashes are reported by “up to 85% of menopausal women,” and that “both hormone therapy and nonhormonal regimens can help to relieve vasomotor symptoms.”
| Study | What was studied | What it found | Limit |
|---|---|---|---|
| 1998 review of the Climara 7-day patch (Gynecological Endocrinology) | Two 11-week placebo-controlled studies of one brand’s 7-day patch at two doses, compared with oral estrogen. | Both patch doses had a positive effect on climacteric symptoms, and tolerance was good. | Covers one brand, from 1998. |
| 2003 Thai trial of a weekly estradiol patch | 50 women followed for six months on a once-a-week estradiol patch. | The average climacteric score fell from 27.18 at the start to 12.18 at six months. At least 94% of patches were not dislodged more than one quarter. | Open-label, one hospital, no comparison group. The most common skin irritation was itching. |
| 2002 randomized trial (Metabolism: clinical and experimental) (PubMed record) | 60 women in early postmenopause enrolled, 54 completed 24 weeks, with groups on diet, simvastatin, oral estrogen or an estrogen patch. | LDL cholesterol fell 26 mg/dL (11%) from baseline with the patch. Only simvastatin was significantly better than diet alone. | Measured cholesterol, not hot flashes. The authors say statins are preferred for more severe disease. |
| 2017 systematic review in the Journal of Women’s Health | Six studies of healthy women aged 50 to 79 who used transdermal estrogen. | “Some evidence suggestive of protective cardiovascular effects,” including a decrease in stroke risk and no increase in coronary heart disease, death or heart attack. | The authors say further randomized trials with longer follow-up are needed. |
The 2017 review’s background also notes studies linking oral hormone therapy with cardiovascular events and breast cancer, which is one reason many women ask about the patch. The review found limited data on cardiovascular outcomes with the patch itself.
What are the side effects and warning signs?
Weight Watchers’ article lists the common side effects of estrogen therapy in general as “breakthrough bleeding, breast tenderness, nausea, headache, bloating, fluid retention, and leg cramps.” It also warns that “switching to a different prescription estrogen product could cause different side effects than what you’re used to,” so tell your prescriber about any change.
Get medical help right away for any of these:
- Severe headache or sudden vision changes
- Chest pain or shortness of breath
- Leg swelling, pain or warmth, which can be a sign of a blood clot
- Sudden weakness, numbness or difficulty speaking, which can be a sign of stroke
- Severe abdominal pain
Unusual vaginal bleeding “always merits a quick trip to get checked out,” according to the same article. Tell your prescriber if you have a family history of blood clots, or a history of high blood pressure, migraines, smoking or liver dysfunction, since those can affect which option is right for you.
Can I cut, stretch or skip my patch until supply returns?
Don’t. Weight Watchers’ medical director, Nisha Patel, M.D., puts it bluntly: “please don’t try to MacGyver your hormone therapy.” Bradley Gynecology says changing your dose, cutting patches, extending the time between applications or stopping treatment without medical guidance “can affect how well your symptoms are controlled.”
Weight Watchers’ article says that stopping without a switch “could result in symptoms of menopause returning, typically within a few days,” and that there aren’t any additional health risks to quitting abruptly. Even so, if you are about to run out, call your prescriber now rather than on the last day.
Questions to ask your prescriber or pharmacist
- Is my exact strength and brand on backorder, and when is a restock expected?
- Can my prescription be sent to another pharmacy?
- Is there a similar patch from another maker that could work for me?
- Could a once-weekly patch or a daily skin product suit me?
- Given my history, which of these options fits best?
- Which non-hormonal option might be worth discussing?
- What will the switch cost me after insurance?
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
